Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
CC transcript
Credit agrmnt [a]
Acq. announced
Appointed director
|
|
IMPAX LABORATORIES INC (IPXL)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2011 |
BW
| Impax and GSK Announce Positive Topline Results of ASCEND-PD Phase III Study of IPX066 in Advanced Parkinson's Disease |
| 07/06/2011 |
BW
| Robbins Umeda LLP Announces an Investigation of Impax Laboratories, Inc. |
| 06/30/2011 |
BW
| Impax Laboratories Announces Settlement of Litigation Relating to WELCHOL® Tablets and WELCHOL® Oral Suspension Products |
| 06/06/2011 |
BW
| Impax Laboratories Provides an Update on Recent FDA Site Inspection |
| 06/01/2011 |
BW
| Data on IPX066 ADVANCE-PD and APEX-PD Phase III Studies to be Presented at the International Congress of Parkinson's Disease and Movement Disorders Conference |
| 05/10/2011 |
BW
| Impax Pharmaceuticals Provides an Update on Pipeline Candidate IPX159 |
| 05/06/2011 |
BW
| Impax Laboratories Confirms Patent Suit Relating to Generic Concerta® 18, 27 and 36 mg Tablets |
| 05/06/2011 |
BW
| Impax Laboratories to Present at the Bank of America Merrill Lynch 2011 Health Care Conference |
| 05/03/2011 |
BW
| Impax Laboratories Reports First Quarter 2011 Financial Results |
| 05/02/2011 |
BW
| Impax Laboratories Appoints Mark A. Schlossberg as Senior Vice President and General Counsel |
| 04/14/2011 |
BW
| Impax Laboratories Schedules Conference Call and Webcast for First Quarter 2011 Financial Results |
| 04/11/2011 |
BW
| Impax Laboratories Confirms Patent Challenge Relating to OXYCONTIN® 10, 15, 20, 30, 40, 60, and 80 mg |
| 04/08/2011 |
BW
| Impax Laboratories Enters into Commercialization Agreement with Banner Pharmacaps |
| 04/04/2011 |
BW
| Impax Laboratories Confirms Patent Challenge Relating to DEXILANT® Delayed-Release Capsules, 30 mg and 60 mg |
| 04/01/2011 |
BW
| Data on IPX066 APEX-PD Phase III Study for the Treatment of Early Parkinson's Disease to be Presented at the American Academy of Neurology Conference |
| 03/14/2011 |
BW
| IPX066 Demonstrates Efficacy and Safety in ADVANCE-PD Phase III Study in Treatment of Advanced Parkinson's Disease |
| 03/01/2011 |
BW
| Impax Laboratories to Present at the Cowen & Co. 31st Annual Health Care Conference |
| 02/25/2011 |
BW
| Impax Laboratories to Present at the RBC Capital Markets' Healthcare Conference |
| 02/24/2011 |
BW
| Impax Laboratories Reports Fourth Quarter and Record Full Year 2010 Financial Results |
| 02/18/2011 |
BW
| Impax Laboratories Receives Final FDA Approval for Generic Adoxa® 150 mg Capsules |
| 12/03/2010 |
BW
| Impax Laboratories Confirms Patent Challenge Relating to INTUNIVTM, 4 mg |
| 11/29/2010 |
BW
| Impax Laboratories Confirms Patent Suit Relating to Generic Concerta® 54 mg Tablets |
| 11/26/2010 |
BW
| Impax Laboratories to Present at the Piper Jaffray Annual Healthcare Conference |
| 11/26/2010 |
BW
| Impax Laboratories Confirms Patent Challenge Relating to SIMCOR® Extended-Release Tablets, 1000/20 mg |
| 11/22/2010 |
BW
| Impax Confirms Patent Challenge Relating to WELCHOL® for Oral Suspension, 3.75 gm/packet and 1.875 gm/packet |
| 11/16/2010 |
BW
| Impax Laboratories Receives Final FDA Approval for Generic Allegra-D 60mg/120mg Tablets |
| 11/05/2010 |
BW
| Impax Laboratories to Present at the Credit Suisse 19th Annual Healthcare Conference |
| 11/01/2010 |
BW
| Impax Laboratories Announces Litigation Against Shire Relating to Supply of Generic Adderall XR® |
| 10/04/2010 |
BW
| Impax Laboratories Schedules Conference Call and Webcast for Third Quarter 2010 Financial Results |
| 09/30/2010 |
BW
| Impax Laboratories to Present at the Jefferies 2010 Global SpecPharma and European Healthcare Conference |
| 09/15/2010 |
BW
| Impax Laboratories to Present at the UBS Global Life Sciences Conference |
| 09/08/2010 |
BW
| Impax Laboratories to Present at the Morgan Stanley Global Healthcare Conference |
| 08/03/2010 |
BW
| Impax Laboratories Continues Strong Growth in Revenue, Profit and Earnings in the Second Quarter 2010 |
| 07/22/2010 |
BW
| Impax Laboratories Receives Final FDA Approval for Generic OPANA® ER Tablets |
|
|
|